tripalmitoyl cysteine has been researched along with cysteine in 13 studies
Studies (tripalmitoyl cysteine) | Trials (tripalmitoyl cysteine) | Recent Studies (post-2010) (tripalmitoyl cysteine) | Studies (cysteine) | Trials (cysteine) | Recent Studies (post-2010) (cysteine) |
---|---|---|---|---|---|
14 | 0 | 1 | 40,132 | 418 | 11,457 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 4 (30.77) | 18.2507 |
2000's | 7 (53.85) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bessler, WG; Johnson, RB; Jung, G; Köhl, S; Wiesmüller, K | 1 |
Borges, E; Jung, G; Walden, P; Wiesmüller, KH | 1 |
Nardelli, B; Tam, JP | 1 |
Bessler, WG; Biesert, L; Jung, G; Metzger, JW; Sawyer, WH; Wille, B | 1 |
Calvo-Calle, JM; Clavijo, P; Nardin, EH; Nussenzweig, R; Oliveira, GA; Rose, K; Simon, R; Zeng, W | 1 |
Braunschweiger, I; Inchauspé, G; Jung, G; Langhans, B; Sauerbruch, T; Schweitzer, S; Spengler, U | 1 |
McGuire, TC; Ridgely, SL | 1 |
Brown, LE; Ghosh, S; Jackson, DC; Lau, YF; Zeng, W | 1 |
Heilbrun, M; Kirschning, CJ; Ma, Y; Philipp, MT; Wang, X; Weis, JH; Weis, JJ; Wooten, RM; Yoder, A | 1 |
Braunschweiger, I; Langhans, B; Nattermann, J; Nischalke, HD; Sauerbruch, T; Spengler, U | 1 |
Ali, H; Thangam, ER; Zaidi, AK | 1 |
Ajit, D; Crouse, NR; Nichols, MR; Udan, ML | 1 |
Chai, LY; Joosten, I; Khoo, AL; Koenen, HJ; Netea, MG; Sweep, FC; van der Ven, AJ | 1 |
13 other study(ies) available for tripalmitoyl cysteine and cysteine
Article | Year |
---|---|
Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo.
Topics: Animals; Antibody-Producing Cells; B-Lymphocytes; Blood Physiological Phenomena; Cysteine; Hemolytic Plaque Technique; Lipopeptides; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mitogens; Oligopeptides; Polysaccharides, Bacterial; Spleen; T-Lymphocytes | 1983 |
Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid.
Topics: Amino Acid Sequence; Animals; Cysteine; Epitopes; L-Lactate Dehydrogenase; Lipoproteins; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Ovalbumin; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Vaccines, Synthetic | 1994 |
Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide.
Topics: Animals; Antigen-Presenting Cells; CD4-Positive T-Lymphocytes; CD8 Antigens; Cysteine; Cytotoxicity, Immunologic; HIV Envelope Protein gp120; HIV-1; Immunologic Memory; Macrophages; Mice; Mice, Inbred BALB C; T-Lymphocytes, Cytotoxic; Vaccines, Synthetic; Viral Vaccines | 1993 |
Interaction of immunologically-active lipopeptides with membranes.
Topics: Amino Acid Sequence; B-Lymphocytes; Bacterial Outer Membrane Proteins; Carrier Proteins; Cell Membrane; Cysteine; Electron Spin Resonance Spectroscopy; Escherichia coli Proteins; Fatty Acids; Flow Cytometry; Fluorescein-5-isothiocyanate; Mitogens; Models, Molecular; Molecular Sequence Data; Peptides; Sonication; Tumor Cells, Cultured | 1993 |
Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
Topics: Adjuvants, Immunologic; Alum Compounds; Amino Acid Sequence; Animals; Chemical Phenomena; Chemistry, Physical; Cysteine; Epitopes, B-Lymphocyte; Epitopes, T-Lymphocyte; Malaria Vaccines; Malaria, Falciparum; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Oximes; Plasmodium falciparum; Protozoan Proteins; Vaccines, Synthetic | 1998 |
Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro.
Topics: Adult; Cell Culture Techniques; Cell Division; Cysteine; Epitopes, T-Lymphocyte; Female; Hepacivirus; Hepatitis C Antigens; Hepatitis C, Chronic; Humans; Male; Middle Aged; Peptide Fragments; T-Lymphocytes, Helper-Inducer; Viral Core Proteins; Viral Nonstructural Proteins | 2001 |
Lipopeptide stimulation of MHC class I-restricted memory cytotoxic T lymphocytes from equine infectious anemia virus-infected horses.
Topics: Amino Acid Sequence; Animals; Antigens, Viral; Cysteine; Epitopes; Equine Infectious Anemia; Gene Products, env; Histocompatibility Antigens Class I; Horses; Immunologic Memory; In Vitro Techniques; Infectious Anemia Virus, Equine; Lipoproteins; Molecular Sequence Data; T-Lymphocytes, Cytotoxic; Viral Core Proteins | 2002 |
Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Amino Acid Sequence; Animals; Cells, Cultured; Cysteine; Dendritic Cells; Female; Gonadotropin-Releasing Hormone; Histocompatibility Antigens Class II; Immunoglobulin G; Immunoglobulin M; Injections, Subcutaneous; Lipoproteins; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Solubility; Vaccines, Contraceptive | 2002 |
Tripalmitoyl-S-glyceryl-cysteine-dependent OspA vaccination of toll-like receptor 2-deficient mice results in effective protection from Borrelia burgdorferi challenge.
Topics: Animals; Antibodies, Bacterial; Antigens, Surface; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Cysteine; Lipoproteins; Lyme Disease; Membrane Glycoproteins; Mice; Mice, Inbred C3H; Receptors, Cell Surface; Toll-Like Receptor 2; Toll-Like Receptors; Vaccination | 2003 |
Presentation of the HCV-derived lipopeptide LP20-44 by dendritic cells enhances function of in vitro-generated CD4+ T cells via up-regulation of TLR2.
Topics: Adjuvants, Immunologic; Adult; Antigen Presentation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Cysteine; Dendritic Cells; Female; Granzymes; Hepacivirus; Humans; Immunization; Interferon-gamma; Lipoproteins; Lymphocyte Subsets; Male; Middle Aged; Serine Endopeptidases; Toll-Like Receptor 2; Up-Regulation; Viral Proteins | 2006 |
Distinct roles of Ca2+ mobilization and G protein usage on regulation of Toll-like receptor function in human and murine mast cells.
Topics: Animals; Calcium; Cell Degranulation; Cells, Cultured; Chemokines; Cysteine; Cytokines; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; GTP-Binding Proteins; Humans; Mast Cells; Mice; NF-kappa B; NFATC Transcription Factors; Phosphatidylinositol 3-Kinases; Species Specificity; Toll-Like Receptor 2; Toll-Like Receptors | 2006 |
Toll-like receptors 2 and 4 mediate Abeta(1-42) activation of the innate immune response in a human monocytic cell line.
Topics: Amyloid beta-Peptides; Antibodies; Cell Adhesion; Cell Line; Cysteine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Microscopy, Atomic Force; Monocytes; Peptide Fragments; Polymyxin B; Polysaccharides; Time Factors; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2008 |
Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals.
Topics: Adult; Calcitriol; Cysteine; Cytokines; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Middle Aged; Seasons; Toll-Like Receptor 2; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vitamins | 2011 |